Whilst STn is a terminal glycan, the expression of surface terminal GalNAc structures is unusual in breast cancer as it must be a result of incomplete O-linked glycosylation as our data rules out the cause being lack of COSMC function. The gene discussed is C1GALT1C1; the disease is breast carcinoma.